A Flow-Based Model of the HIV Care Continuum in the United States

Gregg S. Gonsalves, A. David Paltiel, Paul D. Cleary, Michael J. Gill, Mari M. Kitahata, Peter F. Rebeiro, Michael J. Silverberg, Michael Horberg, Alison G. Abraham, Keri N. Althoff, Richard Moore, Ronald J. Bosch, Tian Tang, H. Irene Hall, Edward H. Kaplan

Research output: Contribution to journalArticle

Abstract

Background: Understanding the flow of patients through the continuum of HIV care is critical to determine how best to intervene so that the proportion of HIV-infected persons who are on antiretroviral treatment and virally suppressed is as large as possible. Methods: Using immunological and virological data from the Centers for Disease Control and Prevention and the North American AIDS Cohort Collaboration on Research and Design from 2009 to 2012, we estimated the distribution of time spent in and dropout probability from each stage in the continuum of HIV care. We used these estimates to develop a queueing model for the expected number of patients found in each stage of the cascade. Results: HIV-infected individuals spend an average of about 3.1 months after HIV diagnosis before being linked to care, or dropping out of that stage of the continuum with a probability of 8%. Those who link to care wait an additional 3.7 months on average before getting their second set of laboratory results (indicating engagement in care) or dropping out of care with probability of almost 6%. Those engaged in care spent an average of almost 1 year before achieving viral suppression on antiretroviral therapy or dropping out with average probability 13%. For patients who achieved viral suppression, the average time suppressed on antiretroviral therapy was an average of 4.5 years. Conclusions: Interventions should be targeted to more rapidly identifying newly infected individuals, and increasing the fraction of those engaged in care that achieves viral suppression.

LanguageEnglish (US)
Pages548-553
Number of pages6
JournalJournal of Acquired Immune Deficiency Syndromes
Volume75
Issue number5
DOIs
StatePublished - Aug 15 2017

Fingerprint

Continuity of Patient Care
HIV
Centers for Disease Control and Prevention (U.S.)
Acquired Immunodeficiency Syndrome
Research Design
Therapeutics

Keywords

  • antiretroviral therapy
  • HIV continuum of care
  • operations research
  • queueing model
  • viral suppression

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Gonsalves, G. S., Paltiel, A. D., Cleary, P. D., Gill, M. J., Kitahata, M. M., Rebeiro, P. F., ... Kaplan, E. H. (2017). A Flow-Based Model of the HIV Care Continuum in the United States. Journal of Acquired Immune Deficiency Syndromes, 75(5), 548-553. DOI: 10.1097/QAI.0000000000001429

A Flow-Based Model of the HIV Care Continuum in the United States. / Gonsalves, Gregg S.; Paltiel, A. David; Cleary, Paul D.; Gill, Michael J.; Kitahata, Mari M.; Rebeiro, Peter F.; Silverberg, Michael J.; Horberg, Michael; Abraham, Alison G.; Althoff, Keri N.; Moore, Richard; Bosch, Ronald J.; Tang, Tian; Hall, H. Irene; Kaplan, Edward H.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 75, No. 5, 15.08.2017, p. 548-553.

Research output: Contribution to journalArticle

Gonsalves, GS, Paltiel, AD, Cleary, PD, Gill, MJ, Kitahata, MM, Rebeiro, PF, Silverberg, MJ, Horberg, M, Abraham, AG, Althoff, KN, Moore, R, Bosch, RJ, Tang, T, Hall, HI & Kaplan, EH 2017, 'A Flow-Based Model of the HIV Care Continuum in the United States' Journal of Acquired Immune Deficiency Syndromes, vol. 75, no. 5, pp. 548-553. DOI: 10.1097/QAI.0000000000001429
Gonsalves GS, Paltiel AD, Cleary PD, Gill MJ, Kitahata MM, Rebeiro PF et al. A Flow-Based Model of the HIV Care Continuum in the United States. Journal of Acquired Immune Deficiency Syndromes. 2017 Aug 15;75(5):548-553. Available from, DOI: 10.1097/QAI.0000000000001429
Gonsalves, Gregg S. ; Paltiel, A. David ; Cleary, Paul D. ; Gill, Michael J. ; Kitahata, Mari M. ; Rebeiro, Peter F. ; Silverberg, Michael J. ; Horberg, Michael ; Abraham, Alison G. ; Althoff, Keri N. ; Moore, Richard ; Bosch, Ronald J. ; Tang, Tian ; Hall, H. Irene ; Kaplan, Edward H./ A Flow-Based Model of the HIV Care Continuum in the United States. In: Journal of Acquired Immune Deficiency Syndromes. 2017 ; Vol. 75, No. 5. pp. 548-553
@article{3d398eb99702418aa5c4fcc8ab8207f7,
title = "A Flow-Based Model of the HIV Care Continuum in the United States",
abstract = "Background: Understanding the flow of patients through the continuum of HIV care is critical to determine how best to intervene so that the proportion of HIV-infected persons who are on antiretroviral treatment and virally suppressed is as large as possible. Methods: Using immunological and virological data from the Centers for Disease Control and Prevention and the North American AIDS Cohort Collaboration on Research and Design from 2009 to 2012, we estimated the distribution of time spent in and dropout probability from each stage in the continuum of HIV care. We used these estimates to develop a queueing model for the expected number of patients found in each stage of the cascade. Results: HIV-infected individuals spend an average of about 3.1 months after HIV diagnosis before being linked to care, or dropping out of that stage of the continuum with a probability of 8{\%}. Those who link to care wait an additional 3.7 months on average before getting their second set of laboratory results (indicating engagement in care) or dropping out of care with probability of almost 6{\%}. Those engaged in care spent an average of almost 1 year before achieving viral suppression on antiretroviral therapy or dropping out with average probability 13{\%}. For patients who achieved viral suppression, the average time suppressed on antiretroviral therapy was an average of 4.5 years. Conclusions: Interventions should be targeted to more rapidly identifying newly infected individuals, and increasing the fraction of those engaged in care that achieves viral suppression.",
keywords = "antiretroviral therapy, HIV continuum of care, operations research, queueing model, viral suppression",
author = "Gonsalves, {Gregg S.} and Paltiel, {A. David} and Cleary, {Paul D.} and Gill, {Michael J.} and Kitahata, {Mari M.} and Rebeiro, {Peter F.} and Silverberg, {Michael J.} and Michael Horberg and Abraham, {Alison G.} and Althoff, {Keri N.} and Richard Moore and Bosch, {Ronald J.} and Tian Tang and Hall, {H. Irene} and Kaplan, {Edward H.}",
year = "2017",
month = "8",
day = "15",
doi = "10.1097/QAI.0000000000001429",
language = "English (US)",
volume = "75",
pages = "548--553",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - A Flow-Based Model of the HIV Care Continuum in the United States

AU - Gonsalves,Gregg S.

AU - Paltiel,A. David

AU - Cleary,Paul D.

AU - Gill,Michael J.

AU - Kitahata,Mari M.

AU - Rebeiro,Peter F.

AU - Silverberg,Michael J.

AU - Horberg,Michael

AU - Abraham,Alison G.

AU - Althoff,Keri N.

AU - Moore,Richard

AU - Bosch,Ronald J.

AU - Tang,Tian

AU - Hall,H. Irene

AU - Kaplan,Edward H.

PY - 2017/8/15

Y1 - 2017/8/15

N2 - Background: Understanding the flow of patients through the continuum of HIV care is critical to determine how best to intervene so that the proportion of HIV-infected persons who are on antiretroviral treatment and virally suppressed is as large as possible. Methods: Using immunological and virological data from the Centers for Disease Control and Prevention and the North American AIDS Cohort Collaboration on Research and Design from 2009 to 2012, we estimated the distribution of time spent in and dropout probability from each stage in the continuum of HIV care. We used these estimates to develop a queueing model for the expected number of patients found in each stage of the cascade. Results: HIV-infected individuals spend an average of about 3.1 months after HIV diagnosis before being linked to care, or dropping out of that stage of the continuum with a probability of 8%. Those who link to care wait an additional 3.7 months on average before getting their second set of laboratory results (indicating engagement in care) or dropping out of care with probability of almost 6%. Those engaged in care spent an average of almost 1 year before achieving viral suppression on antiretroviral therapy or dropping out with average probability 13%. For patients who achieved viral suppression, the average time suppressed on antiretroviral therapy was an average of 4.5 years. Conclusions: Interventions should be targeted to more rapidly identifying newly infected individuals, and increasing the fraction of those engaged in care that achieves viral suppression.

AB - Background: Understanding the flow of patients through the continuum of HIV care is critical to determine how best to intervene so that the proportion of HIV-infected persons who are on antiretroviral treatment and virally suppressed is as large as possible. Methods: Using immunological and virological data from the Centers for Disease Control and Prevention and the North American AIDS Cohort Collaboration on Research and Design from 2009 to 2012, we estimated the distribution of time spent in and dropout probability from each stage in the continuum of HIV care. We used these estimates to develop a queueing model for the expected number of patients found in each stage of the cascade. Results: HIV-infected individuals spend an average of about 3.1 months after HIV diagnosis before being linked to care, or dropping out of that stage of the continuum with a probability of 8%. Those who link to care wait an additional 3.7 months on average before getting their second set of laboratory results (indicating engagement in care) or dropping out of care with probability of almost 6%. Those engaged in care spent an average of almost 1 year before achieving viral suppression on antiretroviral therapy or dropping out with average probability 13%. For patients who achieved viral suppression, the average time suppressed on antiretroviral therapy was an average of 4.5 years. Conclusions: Interventions should be targeted to more rapidly identifying newly infected individuals, and increasing the fraction of those engaged in care that achieves viral suppression.

KW - antiretroviral therapy

KW - HIV continuum of care

KW - operations research

KW - queueing model

KW - viral suppression

UR - http://www.scopus.com/inward/record.url?scp=85025616302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85025616302&partnerID=8YFLogxK

U2 - 10.1097/QAI.0000000000001429

DO - 10.1097/QAI.0000000000001429

M3 - Article

VL - 75

SP - 548

EP - 553

JO - Journal of Acquired Immune Deficiency Syndromes

T2 - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 5

ER -